Attenhofer Jost Christine H, Connolly Heidi M, Danielson Gordon K, Bailey Kent R, Schaff Hartzell V, Shen Win-Kuang, Warnes Carole A, Seward James B, Puga Francisco J, Tajik A Jamil
Division of Cardiovascular Diseases, Mayo Clinic, Rochester, MN 55905, USA.
Circulation. 2005 Sep 27;112(13):1953-8. doi: 10.1161/CIRCULATIONAHA.104.493775. Epub 2005 Sep 19.
Sinus venosus atrial septal defect (SVASD) differs from secundum atrial septal defect by its atrial septal location and its association with anomalous pulmonary venous connection (APVC). Data on long-term outcome after surgical repair are limited.
We reviewed outcomes of 115 patients (mean age+/-SD 34+/-23 years) with SVASD who had repair from 1972 through 1996. APVC was present in 112 patients (97%). Early mortality was 0.9%. Complete follow-up was obtained for 108 patients (95%) at 144+/-99 months. Symptomatic improvement was noted in 83 patients (77%), and deterioration was noted in 17 patients (16%). At follow-up, 7 (6%) of 108 patients had sinus node dysfunction, a permanent pacemaker, or both, and 15 (14%) of 108 patients had atrial fibrillation. Older age at repair was predictive of postoperative atrial fibrillation (P=0.033). No reoperations were required during follow-up. Survival was not different from expected for an age- and sex-matched population. Clinical improvement was more common with older age at surgery (P=0.014). Older age at repair (P=0.008) and preoperative New York Heart Association class III or IV (P=0.038) were independent predictors of late mortality.
Operation for SVASD is associated with low morbidity and mortality, and postoperative subjective clinical improvement occurs irrespective of age at surgery. Postoperative atrial fibrillation appears to be related to older age at operation. SVASD repair achieves survival similar to that of a matched population and should be considered whenever repair may impact survival or symptoms.
静脉窦型房间隔缺损(SVASD)与继发孔型房间隔缺损在房间隔位置及其与肺静脉异位连接(APVC)的关联方面存在差异。手术修复后的长期预后数据有限。
我们回顾了1972年至1996年间接受修复的115例SVASD患者(平均年龄±标准差34±23岁)的预后情况。112例患者(97%)存在APVC。早期死亡率为0.9%。108例患者(95%)在144±99个月时获得了完整随访。83例患者(77%)症状改善,17例患者(16%)症状恶化。随访时,108例患者中有7例(6%)出现窦房结功能障碍、植入永久性起搏器或两者皆有,108例患者中有15例(14%)出现心房颤动。修复时年龄较大是术后心房颤动的预测因素(P = 0.033)。随访期间无需再次手术。生存率与年龄和性别匹配的人群预期无差异。手术时年龄较大的患者临床改善更常见(P = 0.014)。修复时年龄较大(P = 0.008)和术前纽约心脏协会心功能分级为III或IV级(P = 0.038)是晚期死亡的独立预测因素。
SVASD手术的发病率和死亡率较低,术后主观临床改善与手术年龄无关。术后心房颤动似乎与手术时年龄较大有关。SVASD修复后的生存率与匹配人群相似,只要修复可能影响生存或症状,就应考虑进行修复。